INS and metabolic disease: In patients with gestational diabetes mellitus, MI metabolic disorders were shown to be potentially exacerbated by aberrant elevation of MIOX activity, resulting in MI depletion and attenuation of insulin signaling, thereby promoting insulin resistance development [77].